Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market

Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market OAKLAND, NJ — 6/28/22 — Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen and other biomaterial-based medical devices, and Linden Capital Partners portfolio company (“Collagen Matrix” or “the Company”), announced today its 510(k) Clearance…

Read More

Collagen Matrix Acquires Sunstar’s GUIDOR® Synthetic Bone Graft & Membrane Business

Collagen Matrix Acquires Sunstar’s GUIDOR® Synthetic Bone Graft & Membrane Business Collagen Matrix, Inc., a global leader in regenerative, collagen-based, xenograft-derived medical devices, and portfolio company of Linden Capital Partners (“Linden”), announced today the acquisition of Sunstar’s Degradable Solutions division (the “Company”), including its GUIDOR® branded line of resorbable synthetic medical implants. Founded in 1999, Degradable…

Read More